SK4642003A3 - Bridged piperazine derivatives - Google Patents

Bridged piperazine derivatives Download PDF

Info

Publication number: SK4642003A3
Authority: SK; Slovakia
Prior art keywords: alkyl; amino; alkylamino; alkylcarbonylamino; alkoxy
Prior art date: 2000-10-19

Application number

SK464-2003A

Other languages

English (en)

Slovak (sk)

Inventor

Laura Cook Blumberg

Matthew Frank Brown

Ronald Paul Gladue

Christopher Stanley Poss

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-19

Filing date

2001-10-04

Publication date

2004-05-04

2001-10-04 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-05-04 Publication of SK4642003A3 publication Critical patent/SK4642003A3/sk

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Tropical Medicine & Parasitology (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
AIDS & HIV (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)

SK464-2003A 2000-10-19 2001-10-04 Bridged piperazine derivatives SK4642003A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US24180400P	2000-10-19	2000-10-19
PCT/IB2001/001844 WO2002032901A2 (fr)	2000-10-19	2001-10-04	Derives de piperazine pontes

Publications (1)

Publication Number	Publication Date
SK4642003A3 true SK4642003A3 (en)	2004-05-04

Family

ID=22912245

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK464-2003A SK4642003A3 (en)	2000-10-19	2001-10-04	Bridged piperazine derivatives

Country Status (38)

Country	Link
US (1)	US20020119961A1 (fr)
EP (1)	EP1326867A2 (fr)
JP (1)	JP2004511558A (fr)
KR (1)	KR20030040548A (fr)
CN (1)	CN1471534A (fr)
AP (1)	AP2001002306A0 (fr)
AR (1)	AR035354A1 (fr)
AU (1)	AU2001292160A1 (fr)
BG (1)	BG107655A (fr)
BR (1)	BR0114697A (fr)
CA (1)	CA2423789A1 (fr)
CZ (1)	CZ20031013A3 (fr)
DO (1)	DOP2001000268A (fr)
EA (1)	EA200300392A1 (fr)
EC (1)	ECSP034561A (fr)
EE (1)	EE200300189A (fr)
GE (1)	GEP20053617B (fr)
GT (1)	GT200100209A (fr)
HN (1)	HN2001000235A (fr)
HR (1)	HRP20030298A2 (fr)
HU (1)	HUP0301442A3 (fr)
IL (1)	IL154912A0 (fr)
IS (1)	IS6747A (fr)
MA (1)	MA26953A1 (fr)
MX (1)	MXPA03003475A (fr)
NO (1)	NO20031572L (fr)
NZ (1)	NZ524742A (fr)
OA (1)	OA12519A (fr)
PA (1)	PA8530901A1 (fr)
PE (1)	PE20020587A1 (fr)
PL (1)	PL362077A1 (fr)
PY (1)	PY0125402A (fr)
SK (1)	SK4642003A3 (fr)
SV (1)	SV2002000694A (fr)
TN (1)	TNSN01144A1 (fr)
WO (1)	WO2002032901A2 (fr)
YU (1)	YU30603A (fr)
ZA (1)	ZA200302157B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA03010255A (es) *	2001-05-10	2005-03-07	Agouron Pharma	Ligandos heterobiciclicos de proteinas de union a fk-506.
EE200400023A (et)	2001-06-20	2004-06-15	Pfizer Products Inc.	Uued sulfoonhappe derivaadid
CZ2004519A3 (cs)	2001-10-22	2004-12-15	Pfizer Products Inc.	Deriváty piperazinu s účinky antagonisty receptoru CCR1
US20050256130A1 (en) *	2002-06-12	2005-11-17	Chemocentryx, Inc.	Substituted piperazines
US7842693B2 (en) *	2002-06-12	2010-11-30	Chemocentryx, Inc.	Substituted piperazines
US7589199B2 (en)	2002-06-12	2009-09-15	Chemocentryx, Inc.	Substituted piperazines
MXPA04012393A (es) *	2002-06-12	2005-06-17	Chemocentryx	Derivados de piperazina 1-aril-4-substituidos para utilizar como antagonistas ccr1 para tratamiento de inflamacion y desordenes inmunes.
US7435831B2 (en) *	2004-03-03	2008-10-14	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
CN1950082B (zh) *	2004-03-03	2013-02-06	凯莫森特里克斯股份有限公司	双环和桥连的含氮杂环化物
GB0409236D0 (en) *	2004-04-26	2004-05-26	Novartis Ag	Organic compounds
KR101268630B1 (ko) *	2008-07-16	2013-05-29	에프. 호프만-라 로슈 아게	심혈관 질환 치료용 신규 헤테로사이클일 화합물
WO2011104307A2 (fr) *	2010-02-25	2011-09-01	Graffinity Pharmaceuticals Gmbh	Ligands destinés à la purification d'anticorps par chromatographie d'affinité
CN101874798B (zh) *	2010-06-29	2012-08-29	北京大学	白三烯a4水解酶与环氧合酶的双功能抑制剂及其用途
CN105294700B (zh) *	2014-07-01	2019-01-08	上海合全药业股份有限公司	一种2-氧代-3,8-二氮杂二环[3.2.1]辛烷-8-羧酸叔丁酯的制备方法
US10231970B2 (en)	2014-09-30	2019-03-19	NV Heterocycles	Methods of producing heteropolycycles via bis-epoxidation
US11274082B2 (en)	2019-05-31	2022-03-15	Ikena Oncology, Inc.	Tead inhibitors and uses thereof
WO2020243423A1 (fr)	2019-05-31	2020-12-03	Ikena Oncology, Inc.	Inhibiteurs de tead et leurs utilisations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE640616A (fr) *	1962-12-19
US3492397A (en) *	1967-04-07	1970-01-27	Warner Lambert Pharmaceutical	Sustained release dosage in the pellet form and process thereof
US4060598A (en) *	1967-06-28	1977-11-29	Boehringer Mannheim G.M.B.H.	Tablets coated with aqueous resin dispersions
US3538214A (en) *	1969-04-22	1970-11-03	Merck & Co Inc	Controlled release medicinal tablets
US4173626A (en) *	1978-12-11	1979-11-06	Merck & Co., Inc.	Sustained release indomethacin
GB8800694D0 (en) *	1988-01-13	1988-02-10	Pfizer Ltd	Antiarrhythmic agents
US5245028A (en) *	1990-08-09	1993-09-14	Warner-Lambert Company	Process for preparing tetracyclic amines useful as cerebrovascular agents
AT403803B (de) *	1996-04-19	1998-05-25	Sanochemia Ltd	Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US6207665B1 (en) *	1997-06-12	2001-03-27	Schering Aktiengesellschaft	Piperazine derivatives and their use as anti-inflammatory agents
ID27544A (id) *	1998-08-18	2001-04-12	Ucb Sa	Agonis dan antagonis muskarinat
GB9905010D0 (en) *	1999-03-04	1999-04-28	Merck Sharp & Dohme	Therapeutic agents
US6432976B1 (en) *	1999-10-29	2002-08-13	Merck & Co., Inc.	8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists

2001
- 2001-10-04 HU HU0301442A patent/HUP0301442A3/hu unknown
- 2001-10-04 JP JP2002536283A patent/JP2004511558A/ja not_active Withdrawn
- 2001-10-04 EP EP01972389A patent/EP1326867A2/fr not_active Withdrawn
- 2001-10-04 HR HR20030298A patent/HRP20030298A2/hr not_active Application Discontinuation
- 2001-10-04 MX MXPA03003475A patent/MXPA03003475A/es unknown
- 2001-10-04 OA OA1200300093A patent/OA12519A/en unknown
- 2001-10-04 BR BR0114697-1A patent/BR0114697A/pt not_active IP Right Cessation
- 2001-10-04 YU YU30603A patent/YU30603A/sh unknown
- 2001-10-04 AU AU2001292160A patent/AU2001292160A1/en not_active Abandoned
- 2001-10-04 WO PCT/IB2001/001844 patent/WO2002032901A2/fr not_active Ceased
- 2001-10-04 PL PL01362077A patent/PL362077A1/xx not_active Application Discontinuation
- 2001-10-04 KR KR10-2003-7005422A patent/KR20030040548A/ko not_active Ceased
- 2001-10-04 CA CA002423789A patent/CA2423789A1/fr not_active Abandoned
- 2001-10-04 CZ CZ20031013A patent/CZ20031013A3/cs unknown
- 2001-10-04 AP APAP/P/2001/002306A patent/AP2001002306A0/en unknown
- 2001-10-04 GE GE5131A patent/GEP20053617B/en unknown
- 2001-10-04 NZ NZ524742A patent/NZ524742A/xx unknown
- 2001-10-04 CN CNA018176925A patent/CN1471534A/zh active Pending
- 2001-10-04 EA EA200300392A patent/EA200300392A1/ru unknown
- 2001-10-04 EE EEP200300189A patent/EE200300189A/xx unknown
- 2001-10-04 IL IL15491201A patent/IL154912A0/xx unknown
- 2001-10-04 SK SK464-2003A patent/SK4642003A3/sk not_active Application Discontinuation
- 2001-10-05 US US09/972,177 patent/US20020119961A1/en not_active Abandoned
- 2001-10-09 PY PY200100125402A patent/PY0125402A/es unknown
- 2001-10-17 GT GT200100209A patent/GT200100209A/es unknown
- 2001-10-17 PE PE2001001030A patent/PE20020587A1/es not_active Application Discontinuation
- 2001-10-17 AR ARP010104880A patent/AR035354A1/es unknown
- 2001-10-18 DO DO2001000268A patent/DOP2001000268A/es unknown
- 2001-10-18 HN HN2001000235A patent/HN2001000235A/es unknown
- 2001-10-18 TN TNTNSN01144A patent/TNSN01144A1/fr unknown
- 2001-10-18 PA PA20018530901A patent/PA8530901A1/es unknown
- 2001-10-18 SV SV2001000694A patent/SV2002000694A/es unknown
2003
- 2003-03-17 IS IS6747A patent/IS6747A/is unknown
- 2003-03-18 ZA ZA200302157A patent/ZA200302157B/en unknown
- 2003-03-20 BG BG107655A patent/BG107655A/bg unknown
- 2003-04-08 NO NO20031572A patent/NO20031572L/no unknown
- 2003-04-08 MA MA27098A patent/MA26953A1/fr unknown
- 2003-04-16 EC EC2003004561A patent/ECSP034561A/es unknown

Also Published As

Publication number	Publication date
NO20031572D0 (no)	2003-04-08
HUP0301442A2 (hu)	2003-12-29
KR20030040548A (ko)	2003-05-22
GT200100209A (es)	2002-06-04
EP1326867A2 (fr)	2003-07-16
MA26953A1 (fr)	2004-12-20
CA2423789A1 (fr)	2002-04-25
WO2002032901A2 (fr)	2002-04-25
BR0114697A (pt)	2003-11-18
NO20031572L (no)	2003-06-10
AU2001292160A1 (en)	2002-04-29
PA8530901A1 (es)	2003-11-12
NZ524742A (en)	2004-12-24
PL362077A1 (en)	2004-10-18
AR035354A1 (es)	2004-05-12
DOP2001000268A (es)	2002-05-30
SV2002000694A (es)	2002-12-02
IS6747A (is)	2003-03-17
YU30603A (sh)	2006-05-25
CZ20031013A3 (en)	2004-03-17
US20020119961A1 (en)	2002-08-29
EE200300189A (et)	2003-10-15
ECSP034561A (es)	2003-06-25
IL154912A0 (en)	2003-10-31
EA200300392A1 (ru)	2003-10-30
CN1471534A (zh)	2004-01-28
HN2001000235A (es)	2001-11-07
PY0125402A (es)	2004-06-01
OA12519A (en)	2006-05-30
HRP20030298A2 (en)	2005-02-28
BG107655A (bg)	2004-01-30
MXPA03003475A (es)	2003-07-14
WO2002032901A3 (fr)	2002-07-25
ZA200302157B (en)	2004-04-22
GEP20053617B (en)	2005-09-26
JP2004511558A (ja)	2004-04-15
PE20020587A1 (es)	2002-07-08
TNSN01144A1 (fr)	2005-11-10
HUP0301442A3 (en)	2007-03-28
AP2001002306A0 (en)	2001-12-31

Legal Events

Date	Code	Title	Description
2010-10-07	FC9A	Refused patent application

Publication	Publication Date	Title
CZ20023154A3 (cs)	2003-11-12	Nové deriváty piperazinu
DE60221569T2 (de)	2008-04-30	Acrylsulfonamidderivate zur verwendung als ccr3-antagonisten bei der behandlung von inflammatorischen und immunologischen erkrankungen
DE60014130T2 (de)	2006-03-09	Heterocyclische verbindungen verwendbar als tyrosinkinase inhibitoren
EP0690851B1 (fr)	1999-05-19	Derives de guanidine efficaces en therapeutique
CA2463272C (fr)	2009-11-17	Derives de piperazine a activite antagoniste du recepteur ccr1
CZ20012150A3 (cs)	2001-11-14	Sulfonamid hydroxydifenylmočoviny jako antagonista IL-8 receptoru
CZ20031013A3 (en)	2004-03-17	Bridged piperazine derivatives
JP2005537279A (ja)	2005-12-08	ピペリジン誘導体と、受容体ＣＣＲ１に結合するＭＩＰ−１αの選択的阻害剤としてのその使用
SK15722003A3 (sk)	2004-08-03	Deriváty kyseliny sulfónovej a ich použitie
US20030004189A1 (en)	2003-01-02	Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
JP2001501918A (ja)	2001-02-13	Ｉｌ―８レセプターアンタゴニスト
EP2528604B1 (fr)	2017-11-22	Inhibiteurs d'acyl pipéridine d'époxyde hydrolase soluble
US5137895A (en)	1992-08-11	3-[N-aroyl(or thioaroyl)aminomethyl]-3-quinuclidinols
KR20050028036A (ko)	2005-03-21	Ｃｃｒ1 케모카인 수용체의 길항제로서 비시클릭 피페리딘유도체
SK13282002A3 (sk)	2003-02-04	Sulfónamidové substituované difenylmočovinové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
MXPA99001533A (en)	1999-06-01	Il-8 receptor antagonists
AU2002337408A1 (en)	2003-05-06	Piperazine derivatives with CCR1 receptor antagonist activity